MAIA Completes Enrollment
MAIA Biotechnology completes international enrollment in Part C of Phase 2 THIO-101 expansion trial in third-line non-small cell lung cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.